Artal Group’s Repare Therapeutics RPTX Stock Holding History

Artal Group’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-700,000	Closed	-$3.3M	–	127
2024 Q1	$3.3M	Hold	700,000	–	–	0.09%	74
2023 Q4	$5.11M	Hold	700,000	–	–	0.17%	50
2023 Q3	$8.46M	Hold	700,000	–	–	0.37%	46
2023 Q2	$7.41M	Hold	700,000	–	–	0.24%	58
2023 Q1	$6.89M	Hold	700,000	–	–	0.41%	52
2022 Q4	$10.3M	Hold	700,000	–	–	0.59%	42
2022 Q3	$8.49M	Hold	700,000	–	–	0.44%	47
2022 Q2	$9.79M	Hold	700,000	–	–	0.54%	37
2022 Q1	$9.97M	Hold	700,000	–	–	0.42%	47
2021 Q4	$14.8M	Buy	700,000 +150,000	+27%	+$3.53M	0.43%	54
2021 Q3	$14.4M	Hold	550,000	–	–	0.35%	65
2021 Q2	$17.1M	Hold	550,000	–	–	0.39%	61
2021 Q1	$16.9M	Sell	550,000 -20,000	-4%	-$679K	0.36%	73
2020 Q4	$19.6M	Hold	570,000	–	–	0.45%	59
2020 Q3	$17.5M	Sell	570,000 -30,000	-5%	-$794K	0.58%	51
2020 Q2	$18.6M	Buy	+600,000	New	+$19.3M	0.63%	47

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Aquilo Capital Management San Francisco, California $37.1M AUM 41.76% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return